Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force

Stephen G. Weber, Susan S. Huang, Shannon Oriola, W. Charles Huskins, Gary A. Noskin, Kathleen Harriman, Russell N. Olmsted, Marc Bonten, Tammy Lundstrom, Michael W. Climo, Mary Claire Roghmann, Cathryn L. Murphy, Tobi B. Karchmer

Research output: Contribution to journalArticleResearchpeer-review

87 Citations (Scopus)

Abstract

Legislation aimed at controlling antimicrobial-resistant pathogens through the use of active surveillance cultures to screen hospitalized patients has been introduced in at least 2 US states. In response to the proposed legislation, the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology, Inc., (APIC) have developed this joint position statement. Both organizations are dedicated to combating health care-associated infections with a wide array of methods, including the use of active surveillance cultures in appropriate circumstances. This position statement reviews the proposed legislation and the rationale for use of active surveillance cultures, examines the scientific evidence supporting the use of this strategy, and discusses a number of unresolved issues surrounding legislation mandating use of active surveillance cultures. The following 5 consensus points are offered. (1) Although reducing the burden of antimicrobial-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), is of preeminent importance, the APIC and the SHEA do not support legislation to mandate use of active surveillance cultures to screen for MRSA, VRE, or other antimicrobial-resistant pathogens. (2) The SHEA and the APIC support the continued development, validation, and application of efficacious and cost-effective strategies for the prevention of infections caused by MRSA, VRE, and other antimicrobial-resistant and antimicrobial-susceptible pathogens. (3) The APIC and the SHEA welcome efforts by health care consumers, together with private, local, state, and federal policy makers, to focus attention on and formulate solutions for the growing problem of antimicrobial resistance and health care-associated infections. (4) The SHEA and the APIC support ongoing additional research to determine and optimize the appropriateness, utility, feasibility, and cost-effectiveness of using active surveillance cultures to screen both lower-risk and high-risk populations. (5) The APIC and the SHEA support stronger collaboration between state and local public health authorities and institutional infection prevention and control experts.

Original languageEnglish
Pages (from-to)73-85
Number of pages13
JournalAmerican Journal of Infection Control
Volume35
Issue number2
DOIs
Publication statusPublished - 1 Mar 2007
Externally publishedYes

Fingerprint

Advisory Committees
Methicillin-Resistant Staphylococcus aureus
Epidemiology
Joints
Delivery of Health Care
Legislation
Cross Infection
Vancomycin-Resistant Enterococci
Infection Control
Administrative Personnel
Cost-Benefit Analysis
Public Health
Organizations
Costs and Cost Analysis

Cite this

Weber, Stephen G. ; Huang, Susan S. ; Oriola, Shannon ; Huskins, W. Charles ; Noskin, Gary A. ; Harriman, Kathleen ; Olmsted, Russell N. ; Bonten, Marc ; Lundstrom, Tammy ; Climo, Michael W. ; Roghmann, Mary Claire ; Murphy, Cathryn L. ; Karchmer, Tobi B. / Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci : Position statement from the Joint SHEA and APIC Task Force. In: American Journal of Infection Control. 2007 ; Vol. 35, No. 2. pp. 73-85.
@article{038c20bd9fdc430ca8f32587076b3f0a,
title = "Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force",
abstract = "Legislation aimed at controlling antimicrobial-resistant pathogens through the use of active surveillance cultures to screen hospitalized patients has been introduced in at least 2 US states. In response to the proposed legislation, the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology, Inc., (APIC) have developed this joint position statement. Both organizations are dedicated to combating health care-associated infections with a wide array of methods, including the use of active surveillance cultures in appropriate circumstances. This position statement reviews the proposed legislation and the rationale for use of active surveillance cultures, examines the scientific evidence supporting the use of this strategy, and discusses a number of unresolved issues surrounding legislation mandating use of active surveillance cultures. The following 5 consensus points are offered. (1) Although reducing the burden of antimicrobial-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), is of preeminent importance, the APIC and the SHEA do not support legislation to mandate use of active surveillance cultures to screen for MRSA, VRE, or other antimicrobial-resistant pathogens. (2) The SHEA and the APIC support the continued development, validation, and application of efficacious and cost-effective strategies for the prevention of infections caused by MRSA, VRE, and other antimicrobial-resistant and antimicrobial-susceptible pathogens. (3) The APIC and the SHEA welcome efforts by health care consumers, together with private, local, state, and federal policy makers, to focus attention on and formulate solutions for the growing problem of antimicrobial resistance and health care-associated infections. (4) The SHEA and the APIC support ongoing additional research to determine and optimize the appropriateness, utility, feasibility, and cost-effectiveness of using active surveillance cultures to screen both lower-risk and high-risk populations. (5) The APIC and the SHEA support stronger collaboration between state and local public health authorities and institutional infection prevention and control experts.",
author = "Weber, {Stephen G.} and Huang, {Susan S.} and Shannon Oriola and Huskins, {W. Charles} and Noskin, {Gary A.} and Kathleen Harriman and Olmsted, {Russell N.} and Marc Bonten and Tammy Lundstrom and Climo, {Michael W.} and Roghmann, {Mary Claire} and Murphy, {Cathryn L.} and Karchmer, {Tobi B.}",
year = "2007",
month = "3",
day = "1",
doi = "10.1016/j.ajic.2007.01.001",
language = "English",
volume = "35",
pages = "73--85",
journal = "American Journal of Infection Control",
issn = "0161-6005",
publisher = "Mosby Inc.",
number = "2",

}

Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci : Position statement from the Joint SHEA and APIC Task Force. / Weber, Stephen G.; Huang, Susan S.; Oriola, Shannon; Huskins, W. Charles; Noskin, Gary A.; Harriman, Kathleen; Olmsted, Russell N.; Bonten, Marc; Lundstrom, Tammy; Climo, Michael W.; Roghmann, Mary Claire; Murphy, Cathryn L.; Karchmer, Tobi B.

In: American Journal of Infection Control, Vol. 35, No. 2, 01.03.2007, p. 73-85.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci

T2 - Position statement from the Joint SHEA and APIC Task Force

AU - Weber, Stephen G.

AU - Huang, Susan S.

AU - Oriola, Shannon

AU - Huskins, W. Charles

AU - Noskin, Gary A.

AU - Harriman, Kathleen

AU - Olmsted, Russell N.

AU - Bonten, Marc

AU - Lundstrom, Tammy

AU - Climo, Michael W.

AU - Roghmann, Mary Claire

AU - Murphy, Cathryn L.

AU - Karchmer, Tobi B.

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Legislation aimed at controlling antimicrobial-resistant pathogens through the use of active surveillance cultures to screen hospitalized patients has been introduced in at least 2 US states. In response to the proposed legislation, the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology, Inc., (APIC) have developed this joint position statement. Both organizations are dedicated to combating health care-associated infections with a wide array of methods, including the use of active surveillance cultures in appropriate circumstances. This position statement reviews the proposed legislation and the rationale for use of active surveillance cultures, examines the scientific evidence supporting the use of this strategy, and discusses a number of unresolved issues surrounding legislation mandating use of active surveillance cultures. The following 5 consensus points are offered. (1) Although reducing the burden of antimicrobial-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), is of preeminent importance, the APIC and the SHEA do not support legislation to mandate use of active surveillance cultures to screen for MRSA, VRE, or other antimicrobial-resistant pathogens. (2) The SHEA and the APIC support the continued development, validation, and application of efficacious and cost-effective strategies for the prevention of infections caused by MRSA, VRE, and other antimicrobial-resistant and antimicrobial-susceptible pathogens. (3) The APIC and the SHEA welcome efforts by health care consumers, together with private, local, state, and federal policy makers, to focus attention on and formulate solutions for the growing problem of antimicrobial resistance and health care-associated infections. (4) The SHEA and the APIC support ongoing additional research to determine and optimize the appropriateness, utility, feasibility, and cost-effectiveness of using active surveillance cultures to screen both lower-risk and high-risk populations. (5) The APIC and the SHEA support stronger collaboration between state and local public health authorities and institutional infection prevention and control experts.

AB - Legislation aimed at controlling antimicrobial-resistant pathogens through the use of active surveillance cultures to screen hospitalized patients has been introduced in at least 2 US states. In response to the proposed legislation, the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology, Inc., (APIC) have developed this joint position statement. Both organizations are dedicated to combating health care-associated infections with a wide array of methods, including the use of active surveillance cultures in appropriate circumstances. This position statement reviews the proposed legislation and the rationale for use of active surveillance cultures, examines the scientific evidence supporting the use of this strategy, and discusses a number of unresolved issues surrounding legislation mandating use of active surveillance cultures. The following 5 consensus points are offered. (1) Although reducing the burden of antimicrobial-resistant pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), is of preeminent importance, the APIC and the SHEA do not support legislation to mandate use of active surveillance cultures to screen for MRSA, VRE, or other antimicrobial-resistant pathogens. (2) The SHEA and the APIC support the continued development, validation, and application of efficacious and cost-effective strategies for the prevention of infections caused by MRSA, VRE, and other antimicrobial-resistant and antimicrobial-susceptible pathogens. (3) The APIC and the SHEA welcome efforts by health care consumers, together with private, local, state, and federal policy makers, to focus attention on and formulate solutions for the growing problem of antimicrobial resistance and health care-associated infections. (4) The SHEA and the APIC support ongoing additional research to determine and optimize the appropriateness, utility, feasibility, and cost-effectiveness of using active surveillance cultures to screen both lower-risk and high-risk populations. (5) The APIC and the SHEA support stronger collaboration between state and local public health authorities and institutional infection prevention and control experts.

UR - http://www.scopus.com/inward/record.url?scp=33847258216&partnerID=8YFLogxK

U2 - 10.1016/j.ajic.2007.01.001

DO - 10.1016/j.ajic.2007.01.001

M3 - Article

VL - 35

SP - 73

EP - 85

JO - American Journal of Infection Control

JF - American Journal of Infection Control

SN - 0161-6005

IS - 2

ER -